Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
This article has been retracted. Please see the Retraction Notice for more detail: 10.1186/s12906-015-0733-1
Saved in:
Main Authors: | Cheng Liu (Author), Xia Yuan (Author), Le Tao (Author), Zhuoan Cheng (Author), Xiuqin Dai (Author), Xia Sheng (Author), Dongying Xue (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uncovering the potential mechanism of Xue Fu Zhu Yu Decoction in the treatment of intracerebral hemorrhage
by: Dao-jin Xue, et al.
Published: (2022) -
Xue-fu-Zhu-Yu decoction protects rats against retinal ischemia by downregulation of HIF-1α and VEGF via inhibition of RBP2 and PKM2
by: Shu-Qiu Tan, et al.
Published: (2017) -
Retraction: Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells
by: Frontiers Editorial Office
Published: (2023) -
Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells
by: Dingqi Zhang, et al.
Published: (2020) -
The analgesic effects of Yu-Xue-Bi tablet (YXB) on mice with inflammatory pain by regulating LXA4-FPR2-TRPA1 pathway
by: Ying Liu, et al.
Published: (2024)